Axq Capital »

Enliven Therapeutics shares owned by Axq Capital

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Axq Capital from 13F filings

Historical chart of Axq Capital investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by Axq Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by Axq Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $219k 14k 15.40

More positions owned by Axq Capital

Bellring Brands Common Stock (BRBR)
Rocket Cos Com Cl A (RKT)
O'reilly Automotive (ORLY)
UnitedHealth (UNH)
Microsoft Corporation (MSFT)
Xylem (XYL)
Sofi Technologies (SOFI)
Duolingo Cl A Com (DUOL)
Marsh & McLennan Companies
Honeywell International (HON)
Blackrock (BLK)
Stryker Corporation (SYK)
NVIDIA Corporation (NVDA)
Interactive Brokers Group In Com Cl A (IBKR)
Lennar Corp Cl A (LEN)

View all positions for Axq Capital

Top funds holding Enliven Therapeutics

OrbiMed Advisors
FMR
Commodore Capital
Vestal Point Capital
Fairmount Funds Management
BlackRock
Polar Capital Holdings
VR Adviser
Vanguard Group
Henderson Group
Point72 Asset Management
Novo A/S
Blackstone Group
Capital Research Global Investors
Pictet Asset Management Holding SA

View all funds holding Enliven Therapeutics